Accreditation & AIFA
EACCME® Accreditation
Accreditation Statement
The IAPRD 2026 – 31st World Congress on Parkinson’s Disease and Related Disorders, Milan, Italy 11/11/2026 – 14/11/2026, has been accredited by the European Accreditation Council for Continuing Medical Education (EACCME®) with 17.0 European CME credits (ECMEC®s). Each medical specialist should claim only those hours of credit that he/she actually spent in the educational activity.
Through an agreement between the Union Européenne des Médecins Spécialistes and the American Medical Association, physicians may convert EACCME® credits to an equivalent number of AMA PRA Category 1 CreditsTM. Information on the process to convert EACCME® credit to AMA credit can be found at https://edhub.ama-assn.org/pages/applications.
Live educational activities, occurring outside of Canada, recognised by the UEMS-EACCME® for ECMEC®s are deemed to be Accredited Group Learning Activities (Section 1) as defined by the Maintenance of Certification Program of the Royal College of Physicians and Surgeons of Canada.
Information regarding the conversion of EACCME® credits
Credit will be converted based on one (1) hour of participation equalling one credit for all activities. Physicians wishing to convert EACCME® credits to AMA PRA Category 1 Credit™ will be required to access the AMA website at https://edhub.ama-assn.org/pages/applications to obtain the necessary paperwork and instructions. Physicians and other health care professionals will be required to pay a processing fee to the AMA.
For other countries, please contact the relevant national/regional accreditation authority.
Official Italian Agency for AIFA Procedure
Any Italian pharmaceutical company supporting or participating in a congress held in Italy or abroad is subject to authorization by AIFA (the Italian Drug Agency), according to an Italian Government Decree (Decreto Legislativo 219/06 – art. 124). The request for authorization must be submitted at least 60 days before the event’s start date.
Non-Italian pharmaceutical companies are advised to contact the organizing secretariat or the Official Italian Agency appointed for the AIFA submission by July 1, 2026.
The appointed agency to collect all applications from pharmaceutical companies and file them with AIFA is:
AIM Group International – AIM Education S.r.l.
Viale Enrico Forlanini, 23 20134 Milan, Italy
Tel. +39 02 56601.1
e-mail: aifa@aimgroup.eu / c.ghidoli@aimgroup.eu
Key Deadlines and Required Documents
If a company requires AIFA authorization but is not registered with AIFA and does not have an Italian affiliate, it must register on the AIFA website and begin the process by July 01, 2026. This is a very long process, taking approximately 120 days.
Timeline
- June 14, 2026 (150 days prior): First list of pharma sponsoring companies is due to AIM.
- July 1, 2026: Deadline for pharma companies without an AIFA SIS Code to start the registration process with AIM.
- July 20, 2026 (100 days prior): Deadline for all AIFA procedure documents to be submitted to AIM.
Documents